MARCIA REYNOLDS: Open Payments
NPI 1235103292 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 26 payments from 16 companies in 2025. Trend: 2023 $277 · 2024 $843 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $175 |
| Hologic Sales and Service, LLC | 1 | $133 |
| Otsuka America Pharmaceutical, Inc. | 1 | $119 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| Dexcom, Inc. | 1 | $111 |
| ABBVIE INC. | 2 | $109 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| Novo Nordisk Inc | 1 | $62 |
| PFIZER INC. | 3 | $57 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $47 |
Products named: APTIMA, FASENRA, REXULTI, Auvelity, DEXCOM G7 GSS (161), MAVYRET, Ozempic, PREVNAR 20.
Industry payments across DE — which companies pay providers there.
